Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

APPLIED IMMUNOLOGY

CRISPR comes a-knock-in to reprogram antibodies in vivo

Nature Biotechnology volume 40, pages 1183–1184 (2022)Cite this article

Subjects

Reprogramming of antibody responses in mice is achieved via adeno-associated virus delivery of SaCas9, single guide RNA (sgRNA) and a repair template targeting immunoglobulin genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: In vivo B cell gene-editing mediated by two AAVs.

References

  1. Jeske, A. M., Boucher, P., Curiel, D. T. & Voss, J. E. J. Immunol. 207, 755–764 (2021).

    Article  CAS  Google Scholar 

  2. Mu, Z., Haynes, B. F. & Cain, D. W. Curr. Opin. Virol. 51, 172–178 (2021).

    Article  CAS  Google Scholar 

  3. Nahmad, A. D. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01328-9 (2022).

  4. Balazs, A. B. et al. Nature 481, 81–84 (2011).

    Article  Google Scholar 

  5. Brinkmann, V. & Heusser, C. H. Cell. Immunol. 152, 323–332 (1993).

    Article  CAS  Google Scholar 

  6. Nahmad, A. D. et al. Nat. Commun. 11, 5851 (2020).

    Article  CAS  Google Scholar 

  7. Huang, D. et al. Nat. Commun. 11, 5820 (2020).

    Article  Google Scholar 

  8. Moffett, H. F. et al. Sci. Immunol. 4, eaax0644 (2019).

    Article  CAS  Google Scholar 

  9. Hartweger, H. et al. J. Exp. Med. 216, 1301–1310 (2019).

    Article  CAS  Google Scholar 

  10. Rurik, J. G. et al. Science 375, 91–96 (2022).

    Article  CAS  Google Scholar 

  11. Gillmore, J. D. et al. N. Engl. J. Med. 385, 493–502 (2021).

    Article  CAS  Google Scholar 

  12. Wardemann, H. et al. Science 301, 1374–1377 (2003).

    Article  CAS  Google Scholar 

  13. Chandler, R. J., Sands, M. S. & Venditti, C. P. Hum. Gene Ther. 28, 314–322 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Molecular Immunology, Rockefeller University, New York, NY, USA

    Harald Hartweger & Michel C. Nussenzweig

  2. Howard Hughes Medical Institute, Rockefeller University, New York, NY, USA

    Michel C. Nussenzweig

Authors
  1. Harald Hartweger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel C. Nussenzweig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harald Hartweger.

Ethics declarations

Competing interests

H.H. and M.C.N. are co-inventors on patent applications relating to B-cell gene-editing (“Antibody gene editing in B lymphocytes,” US patent application numbers 62/877,982, 62/991,482 and 16/938,132; and “Antibody gene editing in B lymphocytes and co-expression of cargo protein,” PCT application no. PCT/US2021/23026). M.C.N. is an inventor on a patent on 3BNC117 (PTC/US2012/038400).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hartweger, H., Nussenzweig, M.C. CRISPR comes a-knock-in to reprogram antibodies in vivo. Nat Biotechnol 40, 1183–1184 (2022). https://doi.org/10.1038/s41587-022-01299-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01299-x

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research